Rita Ojeil is a Health economist and strategist with deep expertise in health economics, outcomes research (HEOR), real-world evidence (RWE), and strategic consulting analytics. As the COO of Carexso, Rita has successfully led multiple pivotal initiatives, including driving key disease registries across the region, enhancing Site Management Organization (SMO) capabilities, and advancing patient-centric healthcare solutions through robust RWE frameworks including HEOR, Health policy and registries.Rita’s ability to design and manage innovative healthcare registries has positioned her as a regional expert in evidence generation and data-driven policy formulation. Her portfolio includes over 140 HEOR evaluations, 30 patient support programs, and 45 outcome-based managed entry agreements, underscoring her commitment to value-driven healthcare transformation.Her contributions extend to landmark projects such as the Saudi EQ-5D valuation and multi-criteria decision analyses (MCDA), as well as consulting roles that have redefined access strategies for pharmaceutical leaders. She has authored 18 impactful publications, spanning white papers, posters, and manuscripts, further solidifying her status as a thought leader in the global healthcare landscape.Renowned for her strategic acumen and leadership, Rita excels in mentoring diverse teams, building collaborative networks, and delivering actionable insights that bridge the gap between data and decision-making. Her steadfast commitment to healthcare innovation and sustainable outcomes continues to inspire and shape her career aspirations and committment to patients centric careYou said:more humble introChatGPT said:ChatGPTHere’s a revised, humbler introduction for your bio:Rita Ojeil is a dedicated professional with extensive experience in health economics, outcomes research (HEOR), and real-world evidence (RWE). Passionate about improving healthcare systems, Rita has contributed to pivotal initiatives, including establishing key disease registries in the region, enhancing SMO capabilities, and delivering actionable consulting analytics for stakeholders.Her journey is marked by collaboration, innovation, and a focus on patient-centric solutions. With 18 publications and a proven track record in managed entry agreements and HEOR evaluations, she remains committed to fostering impactful, evidence-based healthcare transformation.